Share:
Share this content in WeChat
X
Lecture
MR imaging of hepatic tumors: examination technique and diagnostic principle
ZHAO Yan-feng  OUYANG Han 

DOI:10.3969/j.issn.1674-8034.2012.06.011.


[Abstract] There are some relatively unique signal intensity and enhanced feature on MR imaging of various histological types of hepatic tumors. This paper which summarized the key points of scanning parameters and compared the signal and enhanced feature of common tumors of liver, aimed to help clarify the analytical method and further improve the diagnostic ability of MR imaging on hepatic tumors.
[Keywords] Liver neoplasms;Magnetic resonance imaging;Diagnostic techniques and procedures

ZHAO Yan-feng Department of Diagnosis Imaging, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021, China

OUYANG Han * Department of Diagnosis Imaging, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021, China

*Correspondence to: Ouyang H, E-mail: houybj@126.com

Conflicts of interest   None.

Received  2012-05-16
Accepted  2012-09-02
DOI: 10.3969/j.issn.1674-8034.2012.06.011
DOI:10.3969/j.issn.1674-8034.2012.06.011.

[1]
Campeau NG, Johnson CD, Felmlee JP, et al. MR imaging of the abdomen with a phased-array multicoil: prospective clinical evaluation. Radiology, 1995, 195(3): 769-776.
[2]
Keogan MT, Edelman RR. Technologic advances in abdominal MR imaging. Radiology, 2001, 220(2): 310-320.
[3]
Prasad SR, Wang H, Rosas H, et al. Fat-containing lesions of the liver: radiologic-pathologic correlation. Radiographics, 2005, 25(2): 321-331.
[4]
Elsayes KM, Narra VR, Yin Y, et al. Focal hepatic lesions: diagnostic value of enhancement pattern approach with contrast-enhanced 3D gradient-echo MR imaging. Radiographics, 2005, 25(5): 1299-1320.
[5]
Kim TK, Lee KH, Jang HJ, et al. Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1—2 cm) hepatic nodules in patients at high risk for hepatocellular carcinoma. Radiology, 2011, 259(3): 730-738.
[6]
Malayeri AA, El Khouli RH, Zaheer A, et al. Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up. Radiographics, 2011, 31(6): 1773-1791.
[7]
Agnello F, Ronot M, Valla DC, et al. High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis. Radiology, 2012, 262(2): 511-519.
[8]
Taouli B, Vilgrain V, Dumont E, et al. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology, 2003, 226(1): 71-78.
[9]
Parikh T, Drew SJ, Lee VS, et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology, 2008, 246(3): 812-822.
[10]
Taouli B. Diffusion-weighted MR imaging for liver lesion characterization: a critical look. Radiology, 2012, 262(2): 378-380.
[11]
Coenegrachts K, Delanote J, Ter Beek L, et al. Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques. Br J Radiol, 2007, 80(955): 524-531.
[12]
Bruegel M, Gaa J, Waldt S, et al. Diagnosis of hepatic metastasis: comparison of respiration-triggered diffusion-weighted echo-planar MRI and five t2-weighted turbo spin-echo sequences. AJR Am J Roentgenol, 2008, 191(5): 1421-1429.
[13]
Dagnelie PC, Leij-Halfwerk S. Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer. World J Gastroenterol, 2010, 16(13): 1577-1586.
[14]
尤克增,沈智威,曹震, 等. 活体肝细胞凋亡代谢改变的质子磁共振频谱研究. 磁共振成像, 2011, 2(4): 290-295.
[15]
Corbin IR, Buist R, Peeling J, et al. Hepatic 31P MRS in rat models of chronic liver disease: assessing the extent and progression of disease. Gut, 2003, 52(7): 1046-1053.
[16]
Fischbach F, Schirmer T, Thormann M, et al. Quantitative proton magnetic resonance spectroscopy of the normal liver and malignant hepatic lesions at 3.0 Tesla. Eur Radiol, 2008, 18(11): 2549-2558.
[17]
Sherman M. Epidemiology of hepatocellular carcinoma. Oncology, 2010, 78 (Suppl 1): 7-10.
[18]
Lin H, van den Esschert J, Liu C, et al. Systematic review of hepatocellular adenoma in China and other regions. J Gastroenterol Hepatol, 2011, 26(1): 28-35.
[19]
Curvo-Semedo L, Brito JB, Seco MF, et al. The hypointense liver lesion on T2-weighted MR images and what it means. Radiographics, 2010, 30(1): e38.

PREV Liver iron quantification by 3.0 T MRI: calibration on a rabbit model
NEXT Syngo MR peripheral nerve imaging
  



Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn